Actively Recruiting

Age: 7Years - 15Years
All Genders
Healthy Volunteers
NCT07031102

Methacholine Challenge Test in School Children With/Without Asthma RISKA

Led by Helsinki University Central Hospital · Updated on 2025-06-22

260

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study includes a pre-study telephone interview with healthy controls to assess their eligibility for participation. During the study visit, a background information form and an asthma questionnaire are completed. At the study visit, a methacholine challenge test measuring airway hyperresponsiveness and an exhaled nitric oxide measurement are performed. The effect of medication intensification in asthma patients is further assessed through a telephone interview 1-2 months after the medication adjustment.

CONDITIONS

Official Title

Methacholine Challenge Test in School Children With/Without Asthma RISKA

Who Can Participate

Age: 7Years - 15Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy children aged 7 to 15 years, both sexes
  • No asthma diagnosis during childhood for healthy controls
  • No inhaled asthma medication during the past 2 years for healthy controls
  • No wheezing or shortness of breath during the past 2 years for healthy controls
  • Written informed consent from participant and guardian
  • Children aged 7 to 15 years with physician-diagnosed asthma (ICD-10 J45.0/J45.1/J45.9)
  • Inhaled corticosteroid treatment for at least 6 months
  • Well-controlled asthma (c-ACT/ACT score 20 or higher) with no need to intensify medication, or poorly controlled asthma needing medication intensification
Not Eligible

You will not qualify if you...

  • Premature birth before 32 gestational weeks
  • Other chronic cardiopulmonary or neurological conditions affecting airways (excluding asthma)
  • Severe underlying illness such as malignancy
  • Use of beta-blocker medication
  • Active immunological disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

HUS Skin and Allergy Hospital

Helsinki, Finland, 00250

Actively Recruiting

Loading map...

Research Team

J

Janne Burman, PhD, MD

CONTACT

A

Anssi Koivuselkä, Nurse

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here